RxDoctor Payments Data

Brian McKinnon, MD

Otolaryngology · Hagerstown, MDNPI 1316945819

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,170 of the $4,684 with a category attached, or 67.7%. Med-el Corporation accounts for 71.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $3,649 and has fallen 98.1% since, to $69 in 2025.

$4,684in general payments, 2019–2025

Across 24 payments — averaging $195.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Med-el Corporation$3K
  • Cochlear Americas$578
  • Oticon Medical, LLC$215
  • Intersect ENT, Inc.$150
  • Aerin Medical Inc.$106
  • Regeneron Healthcare Solutions, Inc.$96
  • plus $176 from 5 others
$10,000in research payments, 2019–2025

Across 1 payment — averaging $10,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cook Research Incorporated$10K

What the payments were for

  • Consulting fees$3,17068%
  • Travel & lodging$3157%
  • Food & beverage$1,18325%
  • Gifts$170%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,684 in reported general payments places this provider in the 85th percentile of 222 otolaryngology providers in Maryland.

See all otolaryngology providers in Maryland

Medicare billing

Part B allowed, 2024
$31,748
Medicare patients
188
Services billed
387

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocortisone-Acetic AcidHydrocortisone/Acetic Acid15$1,518
Ofloxacin35$466
Azelastine Hcl13$440
Fluticasone Propionate22$381

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Hagerstown

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →